Ganglioneuroma differential diagnosis: Difference between revisions

	Ganglioneuroma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Ganglioneuroma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ganglioneuroma differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ganglioneuroma differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ganglioneuroma differential diagnosis
CDC on Ganglioneuroma differential diagnosis
Ganglioneuroma differential diagnosis in the news
Blogs on Ganglioneuroma differential diagnosis
Directions to Hospitals Treating Ganglioneuroma
Risk calculators and risk factors for Ganglioneuroma differential diagnosis

Revision as of 17:57, 14 August 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 6: / Line 6: @@
 ==Differentiating Ganglioneuroma from other Diseases==
-*Ganglioneuromas are rare tumors that most frequently start in the autonomic nerve cells, which may be in any part of the body. The [[tumor]] are usually noncancerous ([[benign]]).
-*Ganglioneuromas usually occur in people ages 10 to 40. They grow slowly, and may release certain chemicals or [[hormones]].
 ==References==